Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pharmacists

An article in The New York Times reports on an announcement by European regulators that, “there is little evidence that widely used drugs to treat Type 2 diabetes could cause pancreatic inflammation or pancreatic cancer.” The announcement came...
Reuters reports that an experimental leukemia treatment from Roche “delayed disease progression in people with one of the most common forms of blood cancer” longer than commonly used Rituxan. The drug, known as GA101 or obinutuzumab,...
An article in Forbes reports that Riociguat, a drug under development from Bayer, shows “promising” effects for people suffering from two types of pulmonary hypertension. Two new studies examined the effects of treatment for two groups, one...